For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation ...

“For decades, the diabetes world has focused on lowering sugar, not on treating the root cause of the disease nor on stopping ...

For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation in the digestive tract and the absence of a dedicated intestinal transport ...

David Baker, Nobel laureate and UW adjunct professor, gave a public lecture discussing the development and applications of ...

It can acutely raise blood glucose levels by suppressing insulin secretion, but in the long term, it may confer metabolic benefits.

Adequate sleep duration is essential for overall health, but other components of sleep — a consistent bedtime, uninterrupted sleep, daytime function — can also contribute to cardiometabolic health and ...

A recent study by Vanderbilt Health researchers has revealed a greater, detrimental role for B lymphocytes (B cells) in the ...

A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...

His discovery of the protein fragment GLP-1 was crucial in the development of Ozempic, Wegovy and other blockbuster obesity ...

Researchers at Northwestern University have discovered a concealed molecular "control switch" within a protein that plays a crucial role in the body's ability to perceive taste, regulate blood sugar, ...

Drugs long used to treat type 2 diabetes may have previously unrecognized effects on the cells that produce insulin. New research suggests that sulphonylureas could gradually impair these cells’ ...

GLP-1 medications like Ozempic, Wegovy, and Zepbound have quickly become tools for helping people with obesity and diabetes lose weight and lower blood sugar. But emerging research suggests these ...